A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa ...
A Multicenter, Prospective, Randomized, Open-label, Intra-subject Controlled Study of the Efficacy and Safety of ABH001 for the Treatment of Stalled Chronic Cutaneous Wounds Associated With Generalized Epidermolysis Bullosa A Multicenter, Prospective, Randomized, Open-label, Intra-subject Controlled Study of the Efficacy a ...
Epidermolysis Bullosa
Biological: ABH001;Other: Control wound treatment
Shire Regenerative Medicine, Inc.
NULL
Terminated
N/A
N/A
Both
1
Phase 3
United States;Austria;Canada;France;Germany;Poland;Portugal;Spain